US · 1 sources covering this

FDA approves new pancreatic cancer drug that could extend patients' lives

Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

CBS NewsLean L·54m ago
FDA approves new pancreatic cancer drug that could extend patients' lives
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.
Read at CBS News →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/ea24fc8d7b1f7e53f3a331fe42facbe4e1b6661a"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="FDA approves new pancreatic cancer drug that could extend patients&#039; lives"></iframe>

FDA approves new pancreatic cancer drug that could extend patients' lives

How 1 sources are covering this

FDA approves new pancreatic cancer drug that could extend patients' lives

More from US

NYC bar owner sues city, former NYPD brass over shakedown during Eric Adams-era: ‘like mobsters in a bad movie’

New Mexico farmers, residents fear data center's impact on health, bills, jobs

Rich SoCal coastal enclave makes stunning call on controversial Flock cameras

New White House Counsel Isn’t a Yes Man, but He Won’t Say No, Either

Reader

Trust & legal

Across the network

How 1 sources are covering this

FDA approves new pancreatic cancer drug that could extend patients&#039; lives

More from US

NYC bar owner sues city, former NYPD brass over shakedown during Eric Adams-era: &#8216;like mobsters in a bad movie&#8217;

New Mexico farmers, residents fear data center&#039;s impact on health, bills, jobs

Rich SoCal coastal enclave makes stunning call on controversial Flock cameras

New White House Counsel Isn’t a Yes Man, but He Won’t Say No, Either

Reader

Trust & legal

Across the network

FDA approves new pancreatic cancer drug that could extend patients' lives

NYC bar owner sues city, former NYPD brass over shakedown during Eric Adams-era: ‘like mobsters in a bad movie’

New Mexico farmers, residents fear data center's impact on health, bills, jobs